This week, Sorin Group announced that the FDA cleared SmartView, a remote monitoring application for patients with implanted cardiac rhythm management devices. The technology allows physicians whose patients have a Paradym device, Sorin Group's implantable cardioverter-defibrillator (ICD), to monitor them outside of the office.
SmartView is a home health hub that collects data wirelessly from the...